Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Chewy among nine pet companies accused of selling unapproved medication

FDA accuses companies of violating federal law with sale of antibiotics

Saturday 16 December 2023 18:31 GMT
Comments
file image
file image (PA Wire)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Major pet product retailer Chewy and eight other companies have been accused of selling unapproved animal medications.

The Food and Drug Administration leveled the accusations in a letter to the nine companies on Thursday.

The agency alleges that the company violated federal law by selling unapproved medicines containing the antibiotics amoxicillin and penicillin.

The products, targeted at fish and birds, included Aqua-Mox, Aqua-Zithro, Doxycycline and Fishbiotic, the agency said.

FDA Veterinary Medicine Director Tracey Forfa said those antibiotics could fuel the evolution of drug-resistant “super bugs” - posing a risk to humans as well as animals.

“Inappropriate use of medically important antimicrobials contributes to the development of antimicrobial resistance, which affects both human and animal health,” Ms Forfa said in a statement.

The nine companies were ordered to present plans to address violations within 15 days, or else legal action will be escalated. The companies are: American Aquarium Products, Aquanest Biotic, Aquarium Pharmacy, California Veterinary Supply, Chewy Inc., Kraft Drug, Midland Veterinary Services, Silver Lease and Valley Veterinary Clinic.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in